As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
The potential for discovery in peptide research is immense, but it all begins with getting the fundamentals right
The Indian journal of chest diseases & allied sciences
Yes, it is generally taken once daily unless advised otherwise by a doctor
Cell Cycle 14 , 425436 (2015)
Interestingly, interventions that boost NAD + levels resulted in extended lifespan in worms and mice 108,109,111,247 , suggesting a therapeutic potential for raising NAD + in various pathological conditions or age-associated diseases